Multivariate analyses of factors associated with late HAART initiationa.

NOTE. HAART, highly active antiretroviral therapy; FH-Argentina, Fundación Huésped in Buenos Aires, Argentina; FA-Chile, Fundación Arriarán in Santiago, Chile; GHESKIO-Haiti, Le Groupe Haïtien d'Etude du Sarcome de Kaposi et des Infections Opportunistes in Port-au-Prince, Haiti; IHSS/HE-Honduras Instituto Hondureño de Seguridad Social and Hospital de Especialidades in Tegucigalpa, Honduras; INNSZ-México, El Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City, Mexico; and IMTAvH-Perú, El Instituto de Medicina Tropical Alexander von Humboldt in Lima, Perú.aData shown are odds ratios (95% confidence intervals). Estimates are adjusted for all variables in the table as well as date of HAART initiation using a logistic regression model.